SAB Biotherapeutics News

SAB Biotherapeutics | 8-K: Current report

Apr 16 05:20

SAB Biotherapeutics | 10-K: Annual report

Mar 30 01:23

SAB Biotherapeutics | 8-K: Current report

Mar 29 21:37

SAB Biotherapeutics | 8-K: Current report

Mar 9 05:31

SAB Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 24 11:18

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bausch Christoph Lawrence

Feb 24 11:16

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kropotova Alexandra

Feb 24 06:06

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Eddie Joe

Feb 24 06:05

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer King Michael

Feb 24 05:57

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Samuel J

Feb 24 05:46

SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(3.5%),Commodore Capital Master LP(3.5%)

Feb 15 07:07

SAB Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)

Feb 14 20:06

SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%), etc.

Feb 14 19:32

SAB Biotherapeutics | 8-K: Current report

Feb 2 20:55

SAB Biotherapeutics | 8-K: Current report

Jan 27 05:22

SAB Biotherapeutics | 424B5: Prospectus

Jan 27 05:05

SAB Biotherapeutics | 8-K: Current report

Jan 26 06:08

SAB Biotherapeutics | 8-K: Current report

Jan 19 13:00

SAB Biotherapeutics | 8-K: Current report

Jan 3 13:00

SAB Biotherapeutics | DEF 14A: Definitive information statements

Dec 18, 2023 22:34